http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-95112484-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e493dbb326bdb84242fbc9af833f128e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D281-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D281-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate | 1993-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_400ab44efe81937156ad74735d54cc79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1194d5ada1712e9ea1b8879914ba74ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e5e58112bed69d97d1e5c7f30c13be1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9540ef80d74c73912db0c05f35d9fd4 |
| publicationDate | 1997-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-95112484-A |
| titleOfInvention | 2,3,4,5-tetrahydro-1,4-benzothiazepine derivatives, pharmaceutical composition, method of treatment of neurological disorders, seizures, method of nervous system protection, method of synthesis, using |
| abstract | Compounds of the formula where n = 0, 1 or 2; R, R, R and R independently represent H or alkyl (optionally substituted by one or more halogens) R and R independently represent H or alkyl or together represent a group of the formula = NR, where RH, hydroxy, alkyl, phenyl, or alkoxy, each alkyl, phenyl and alkoxy optionally substituted with one or more halogens, R represents (a) H, (b) alkyl, (c) a group of the formula —COR, where R — H, alkyl or phenyl when R and R represent H or alkyl (optionally substituted with one or more halogens) , or (d) a group of the formula -S (O) R, where p = 1 or 2 and R- is alkyl or feni when R and R are H or alkyl (optionally substituted with one or more halogens), each alkyl and phenyl being optionally substituted with one or more halogens, and RR independently represent H, halogen, cyano, nitro, alkyl, alkoxy, alkanoyl, carboxy, alkanoyloxy, carbamoyl (optionally substituted with alkyl) or sulfamoyl (optionally substituted with alkyl of 1 to 4 carbon atoms), each alkyl, alkoxy, alkanoyl, or alkanoyloxy optionally substituted with one or more halogens which are suitable for treating Nia seizures and / or neurological disorders such as epilepsy and / or for use as neuroprotective agents (agents to protect nervous system) to protect against conditions such as stroke. |
| priorityDate | 1992-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.